Home Blood Pressure Monitoring for Hypertension Post-Preeclampsia

Mobile Health Program for Post-Preeclampsia Hypertension

Recruiting N/A Interventional Study
Hypertension (HTN) Preeclampsia Hypertensive Disorders of Pregnancy (HDP)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
University of Pittsburgh · Other
Who this trial is looking for

This trial is looking for women who had high blood pressure during pregnancy and now have high blood pressure after giving birth. Participants will use home blood pressure monitoring and receive virtual coaching to help manage their condition.

Are You a Good Fit for This Trial?

You may be able to join if

  • I had high blood pressure during pregnancy
  • I am a woman
  • I am 10 to 20 years postpartum
  • I have stage 2 high blood pressure with or without treatment

You may not be able to join if

  • I have had a heart attack
  • I have had a stroke
  • I have heart failure
  • I have peripheral artery disease
  • I am male
  • I have children
  • I am not between 10 to 20 years postpartum

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Strategies targeted to optimize hypertension (HTN) control for midlife women after hypertensive disorders of pregnancy (HDP) have not been studied, despite evidence of a critical need. This proposal targets the 10-20 years postpartum as a key time when women have subclinical cardiovascular (CV) sequelae of uncontrolled HTN and are primed for CV prevention interventions. Before proceeding with larg…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Women who had a history of HDP (either gestational HTN or preeclampsia) diagnosed by ACOG guidelines at the time of delivery at Magee-Womens Hospital between 2008 and 2015, thus 10 to 20 years from their index pregnancy complicated by HDP. * Evidence of current stage 2 HTN (BP…
Contacts

Amy Travis

4126413295

travisam@upmc.edu

CONTACT

Samantha Bryan

412-641-1363

myslinskisg@mwri.magee.edu

CONTACT